Avista Healthcare Partners

Name

Avista Healthcare Partners

Legal name

Avista Capital Holdings, L.P.

Website

https://avistahealthcare.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Technology & Software Growth Equity (FSANACAA)

Keywords

• Healthcare private equity
• Healthcare buyout investments
• Healthcare growth capital
• Medtech investment
• Pharmaceutical investments

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Private Equity Fund Management Fees & Carried Interest: As a private equity firm, Avista generates revenue through management fees charged on committed and invested capital of its healthcare-focused funds, plus carried interest (performance fees) on realized investment gains across portfolio companies. This represents the standard PE fund economics of recurring management fees plus performance-based upside.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Avista Healthcare Partners is a New York-based private equity firm founded in 2005 that invests exclusively in mid-sized, growth-oriented healthcare businesses through control buyouts and growth capital investments across six sub-sectors: outsourced pharma and medtech services, consumer healthcare, medical devices, specialty and generic pharmaceuticals, distribution and diagnostics, and healthcare technology. The firm deploys capital from limited partners into portfolio companies and supports those companies with operational expertise, strategic guidance, and add-on acquisitions, having invested over $10 billion across more than 50 healthcare businesses and supported 100+ add-on acquisitions.

Product overview

Avista Healthcare Partners is a New York-based private equity firm (founded in 2005) that invests in mid-sized, growth-oriented healthcare businesses across six sub-sectors: outsourced pharma & medtech services, consumer healthcare, medical devices & medtech, specialty & generic pharmaceuticals, distribution & diagnostics, and healthcare technology. Rather than a single unified product, its offering is a portfolio-plus-add-on-acquisitions architecture spanning over 50 platform healthcare businesses and more than 100 add-on acquisitions, with over $10 billion invested. Its current operating portfolio comprises 21+ active companies including Bentec Medical (silicone medical device components), Birchwell Consumer Health (OTC/skincare platform anchored by Bag Balm), Cooper Consumer Health (European OTC), Cosette Pharmaceuticals (branded specialty pharma including SYMPAZAN, INDOCIN, SPRIX, ZIPSOR, CAMBIA, OTREXUP), EBI (bone growth stimulation), eMolecules (R&D chemicals procurement), GCM (MedTech contract manufacturing), Northern Bio (preclinical CRO focused on gene therapy), OmniAb (antibody discovery), Organogenesis (regenerative wound care), PK Consumer Health (European VMS via Lucovitaal), Probo Medical (diagnostic imaging equipment services), Solmetex (dental water treatment), Spear Education (dental clinical training technology), Taconic Biosciences (genetically engineered research models), Terrats Medical (dental prosthetics), Trillium Health Care Products (OTC CDMO), United BioSource Corporation (pharma patient support services / real-world evidence), Vision Healthcare (European VMS DTC platform), WellSpring Consumer Healthcare (U.S. OTC/personal care), and Xifin (diagnostic revenue cycle SaaS). Its exited portfolio includes Accellent, Acino International, AngioDynamics, Arcadia Consumer Healthcare, BioReliance, Braeburn, Charles River Laboratories, ConvaTec Group, Fisher Scientific, Focus Diagnostics, INC Research, Inform Diagnostics, IVAC, Kinetic Concepts, Lantheus Medical Imaging, MPI Research, National Spine & Pain Centers, Nycomed, OptiNose, Oxford Health Plans, Prometheus Laboratories, RVL Pharmaceuticals, Shoppers Drug Mart Limited, Strategic Partners, Trimb Holding AB, VWR International, Warner Chilcott, and Zest Dental Solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Birchwell Consumer Health: U.S. consumer healthcare platform for OTC and skincare brands launched in 2026.
• PK Consumer Health

Products and services

• Healthcare-focused Private Equity Funds Avista Healthcare Partners manages healthcare-focused private equity funds that invest in mid-sized, growth-oriented healthcare businesses through control buyouts and growth capital. The funds generate returns through management fees on committed and invested capital and carried interest on realized investment gains across portfolio companies. Since inception, Avista and its predecessor funds have deployed over $10 billion of capital across 50+ healthcare businesses.
• Buyout and Growth Capital Investments Avista originates and executes control buyouts of healthcare businesses across outsourced pharma services, medtech, consumer healthcare, medical devices, specialty pharmaceuticals, distribution/diagnostics, and healthcare technology. The firm provides buyout financing, operational support, and strategic guidance to portfolio management teams and supports add-on acquisitions across its portfolio.
• Healthcare Strategic Executive Network Proprietary advisory and operating partner network of 12 Healthcare Strategic Executives (HCS Executives) who provide domain expertise across Avista's portfolio companies and support deal sourcing. HCS Executives include former senior executives from Avantor, Boston Scientific, J&J, Bayer Consumer Care, Merck Consumer Care, Covance, Syneos Health, and other healthcare leaders who sit on portfolio boards.

Quantifiable outcome

• Over $10 billion of capital invested in more than 50 healthcare businesses
• +2 more outcomes

Segments2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

23 partnerships are on record, tiered minor.

• Gemini InvestorsminorOthersGemini Investors sold Bag Balm to Birchwell (an Avista portfolio company), acting as the selling party / seller-side counterparty in the transaction.
• Ropes & Gray LLPminorImplementation/ SI/ Consulting PartnerRopes & Gray LLP served as legal advisor to Avista on transactions and fund matters.
• White & CaseminorImplementation/ SI/ Consulting PartnerWhite & Case served as legal counsel to Avista on the sanotact acquisition.
• AlantraminorImplementation/ SI/ Consulting PartnerAlantra served as M&A advisor on Avista-related healthcare transactions.
• Willkie Farr & Gallagher LLPminorImplementation/ SI/ Consulting PartnerWillkie Farr & Gallagher LLP served as legal advisor to Avista on healthcare transactions.
• Piper SandlerminorImplementation/ SI/ Consulting PartnerPiper Sandler served as financial advisor to Avista on the Bentec Medical transaction.
• McGuireWoodsminorImplementation/ SI/ Consulting PartnerMcGuireWoods served as legal advisor to Avista on the Bentec Medical transaction.
• William BlairminorImplementation/ SI/ Consulting PartnerWilliam Blair served as financial advisor to Avista on the EBI / Xstim transaction.
• Perkins CoieminorImplementation/ SI/ Consulting PartnerPerkins Coie served as legal counsel to Avista on the Precision Medical Products transaction.
• Kekst CNCminorGTM or Marketing PartnerKekst CNC served as a communications / PR firm supporting Avista's transaction announcements and portfolio communications.
• CMS (law firm)minorImplementation/ SI/ Consulting PartnerCMS served as legal counsel to Avista on FLOTTE Beteiligungen-related matters.
• Eight AdvisoryminorImplementation/ SI/ Consulting PartnerEight Advisory served as an advisor to PK on the HealthAid transaction alongside Avista.
• OC&C Strategy ConsultantsminorImplementation/ SI/ Consulting PartnerOC&C served as a strategy advisor to PK on the HealthAid transaction alongside Avista.
• Finvos DMCCminorImplementation/ SI/ Consulting PartnerFinvos DMCC served as an advisor to HealthAid in the Avista-related transaction.
• Higgs LLPminorImplementation/ SI/ Consulting PartnerHiggs LLP served as an advisor to HealthAid in the Avista-related transaction.
• Greyrock Capital GroupminorOthersGreyrock Capital Group was the seller of Bentec Medical to an Avista-related party.
• Hermitage Equity PartnersminorOthersHermitage Equity Partners was the seller of Bentec Medical in a transaction involving Avista.
• Audax Private EquityminorOthersAudax Private Equity was the seller of WellSpring Pharmaceutical Corporation in a transaction involving Avista's portfolio.
• H.I.G. CapitalminorOthersH.I.G. Capital was the seller of Taconic Biosciences in a transaction involving Avista.
• Varsity Healthcare PartnersminorOthersVarsity Healthcare Partners was the seller of Probo Medical in a transaction involving Avista.
• New Water CapitalminorOthersNew Water Capital was the seller of Trillium in a transaction involving Avista.
• Miura PartnersminorOthersMiura Partners was the seller of Terrats Medical in a transaction involving Avista.
• Highridge MedicalminorOthersHighridge Medical was the seller of EBI (a medical device business) in a transaction involving Avista.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Welsh, Carson, Anderson & Stowe: Healthcare-specialist middle-market private equity firm with multiple funds deployed across services, devices, and pharma. Directly comparable to Avista in sector focus, fund size, and platform-plus-add-on strategy.
• Linden Capital Partners: Healthcare-focused middle-market PE firm investing across pharma, medtech, and services. Closely comparable to Avista's sector specialization and mid-market buyout orientation.
• Frazier Healthcare Partners: Healthcare-dedicated private equity firm with buyout and growth franchises. Comparable to Avista in dedicated healthcare focus, mid-market deal sizes, and operating partner model.
• New Mountain Capital: Large healthcare-and-information-services-focused PE firm. Comparable sector overlap (healthcare services, pharma services, distribution) and similar focus on buy-and-build execution.
• Varsity Healthcare Partners: Healthcare-only middle-market PE firm. Previously sold Probo Medical to Avista — directly comparable in sector focus, mid-market check size, and lower-middle-market healthcare focus.
• RoundTable Healthcare Partners: Healthcare-focused PE firm specializing in medical products, devices, and specialty pharma/distribution. Closely comparable mid-market healthcare buyout model with operating partner support.
• DW Healthcare Partners: Healthcare-only PE firm focused on control buyouts of mid-market healthcare companies. Directly comparable to Avista's mid-market healthcare-only mandate and platform build-out strategy.

Broad incumbents

• Bain Capital Healthcare: Healthcare vertical within a major global PE firm with much larger fund size. Broad incumbent competitor with overlapping healthcare services, devices, and pharma interests.
• TPG Capital (TPG Healthcare): Healthcare investing vertical of a large global PE firm. Broad incumbent with overlapping healthcare services and pharma coverage but at significantly larger scale than Avista.

Others

• Audax Private Equity: Mid-market PE firm with healthcare exposure; sold WellSpring Consumer Healthcare to Avista. Adjacent comparable as a healthcare-active generalist PE counterparty in Avista's deal ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/avista-capital-partners

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries22 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A23 records

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avista Healthcare Partners